Forza Innovations

Forza Innovations EBIT CAGR 3Y

The EBIT CAGR (3 Year) of Forza Innovations (FORZ) as of Nov 10, 2026 is 148.80 %. In the previous year, EBIT CAGR (3 Year) was 148.80 % — a change of 0.00% (lower).

EBIT CAGR 3Y

148.80 %

YoY

0.00%

Last updated:

EBIT CAGR (3 Year) of Forza Innovations is 2024 148.80 % . EBIT CAGR (3 Year) of Forza Innovations was 2023 148.80 % . It decreases by 0.00% lower compared to the previous year.

The Forza Innovations EBIT CAGR 3Y history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT CAGR 3Y
Date
EBIT CAGR 3Y
Jan 1, 2017
148.80 USD
Jan 1, 2018
148.80 USD
Jan 1, 2019
148.80 USD
Jan 1, 2020
148.80 USD
Jan 1, 2021
148.80 USD
Jan 1, 2022
148.80 USD
Jan 1, 2023
148.80 USD
Jan 1, 2024
148.80 USD
The Forza Innovations EBIT CAGR 3Y history
YEAREBIT CAGR 3YYoY
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %0.00%
148.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Forza Innovations Stock analysis

What does Forza Innovations do? Forza Innovations, Inc. generates revenue through the sale of its WarmUp product line, which includes the J4 Sport, J4 X, and J4 Fitbelt wearable back compression devices. These devices utilize carbon microfibers and rechargeable lithium batteries to provide therapeutic heat application, targeting stiff and sore muscles. The J4 Sport is designed for patients with chronic conditions like arthritis, osteoporosis, fibromyalgia, and ligament strains, while the J4 Fitbelt focuses on abdominal and lower back muscles or single muscle groups. The J4 Core supports users during physical activities, recovery, and daily routines. The company's revenue streams are derived from direct sales of these therapeutic wearable devices to consumers seeking relief from muscle stiffness and inflammation. The WarmUp series targets health-conscious individuals and patients managing chronic pain conditions, positioning itself as a solution for both active lifestyles and medical needs. Products are sold under the WarmUp brand, with specific models catering to distinct user segments based on their therapeutic requirements. Forza Innovations has acquired ownership of late developmental stage products, including the WarmUp line, which are now its primary revenue-generating assets. The company focuses on the health-tech wearable performance market, emphasizing the therapeutic benefits of heat application through its carbon microfiber technology. Sales are driven by the specific medical and wellness applications of each product model. Forza Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Forza Innovations stock

EBIT CAGR (3 Year) of Forza Innovations is 148.80 % in 2024.

On Eulerpool you can find the complete historical development of EBIT CAGR (3 Year) Forza Innovations since 2006 – with annual values, charts, and detailed analysis.

The 3-year EBIT CAGR shows the compound annual growth rate of EBIT over the past three years.

To evaluate EBIT CAGR (3 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT CAGR (3 Year).

EBIT CAGR (3 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT CAGR (3 Year)'s Forza Innovations historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Forza Innovations

All Key Metrics — Forza Innovations